Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers



  Free Subscription


4 Am Heart J
6 Am J Cardiol
1 Ann Intern Med
1 Ann Thorac Surg
4 Circ Arrhythm Electrophysiol
2 Circ Cardiovasc Qual Outcomes
1 Circulation
2 Clin Cardiol
1 Crit Care Med
3 Eur Heart J
1 Heart
2 Int J Cardiol
5 J Cardiovasc Electrophysiol
1 J Thromb Thrombolysis
2 Pacing Clin Electrophysiol
2 PLoS One
1 Resuscitation

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Heart J

  1. LU DY, Ventoulis I, Liu H, Kudchadkar SM, et al
    Sex-specific cardiac phenotype and clinical outcomes in patients with hypertrophic cardiomyopathy.
    Am Heart J. 2020;219:58-69.
    PubMed         Abstract available

  2. AKAO M, Yamashita T, Suzuki S, Okumura K, et al
    Corrigendum to "Impact of creatinine clearance on clinical outcomes in elderly atrial fibrillation patients receiving apixaban: J-ELD AF Registry subanalysis" Am Heart J (2020).
    Am Heart J. 2020 Apr 13. pii: S0002-8703(20)30092.

  3. COX JL, Parkash R, Foster GA, Xie F, et al
    Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF): A cluster randomized trial of a computerized clinical decision support tool.
    Am Heart J. 2020;224:35-46.
    PubMed         Abstract available

  4. THIBERT MJ, Hawkins NM, Andrade JG
    Clinical decision support for atrial fibrillation in primary care: Steps forward.
    Am Heart J. 2020;224:54-56.

    Am J Cardiol

  5. KUMAR KR, Mandleywala SN, Madias C, Weinstock J, et al
    Single Coil Implantable Cardioverter Defibrillator Leads in Patients With Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2020 Apr 2. pii: S0002-9149(20)30260.
    PubMed         Abstract available

  6. MUNTANE-CAROL G, Almendarez M, Junquera L, Wintzer-Wehekind J, et al
    Long-Term Electrocardiographic Changes and Clinical Outcomes of Transcatheter Aortic Valve Implantation Recipients Without New Postprocedural Conduction Disturbances.
    Am J Cardiol. 2019 Oct 15. pii: S0002-9149(19)31117.
    PubMed         Abstract available

  7. YANG P, Zhao Y, Wong ND
    Development of a Risk Score for Atrial Fibrillation in Adults With Diabetes Mellitus (from the ACCORD Study).
    Am J Cardiol. 2020 Mar 15. pii: S0002-9149(20)30206.
    PubMed         Abstract available

  8. BAYES-DE-LUNA A, Martinez-Selles M, Elosua R, Bayes-Genis A, et al
    Relation of Advanced Interatrial Block to Risk of Atrial Fibrillation and Stroke.
    Am J Cardiol. 2020 Mar 16. pii: S0002-9149(20)30208.
    PubMed         Abstract available

  9. SZYMANSKA A, Platek AE, Dluzniewski M, Szymanski FM, et al
    History of Lyme Disease as a Predictor of Atrial Fibrillation.
    Am J Cardiol. 2020 Mar 13. pii: S0002-9149(20)30209.
    PubMed         Abstract available

  10. ZHANG T, Wang Y, Liang Z, Zhao H, et al
    Effect of Combined Pulmonary Vein and Superior Vena Cava Isolation on the Outcome of Second Catheter Ablation for Paroxysmal Atrial Fibrillation.
    Am J Cardiol. 2020 Apr 3. pii: S0002-9149(20)30280.
    PubMed         Abstract available

    Ann Intern Med

    In AF and stable CAD, rivaroxaban reduced cardiovascular events and mortality more than rivaroxaban plus an antiplatelet.
    Ann Intern Med. 2020;172:JC6.

    Ann Thorac Surg

    Invited Commentary.
    Ann Thorac Surg. 2020;109:76-77.

    Circ Arrhythm Electrophysiol

  13. GARG PK, Guan W, Karger AB, Steffen BT, et al
    Lipoprotein (a) and Risk for Incident Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis.
    Circ Arrhythm Electrophysiol. 2020 Apr 17. doi: 10.1161/CIRCEP.120.008401.

  14. STEINBERG BA, Holmes DN, Pieper K, Allen LA, et al
    Factors Associated with Large Improvements in Health-Related Quality of Life in Patients with Atrial Fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
    Circ Arrhythm Electrophysiol. 2020 Apr 16. doi: 10.1161/CIRCEP.119.007775.
    PubMed         Abstract available

  15. SCHRAM-SERBAN C, Heida A, Roos-Serote MC, Knops P, et al
    Heterogeneity in Conduction Underlies Obesity Related Atrial Fibrillation Vulnerability.
    Circ Arrhythm Electrophysiol. 2020 Apr 17. doi: 10.1161/CIRCEP.119.008161.
    PubMed         Abstract available

  16. TAKAHASHI Y, Yamammoto T, Sekigawa M, Yamaguchi J, et al
    Mapping After Pulmonary Vein Isolation in Persistent Atrial Fibrillation: Insights into the Role of Focal and Rotational Activation during Atrial Fibrillation.
    Circ Arrhythm Electrophysiol. 2020 Apr 17. doi: 10.1161/CIRCEP.120.008511.

    Circ Cardiovasc Qual Outcomes

  17. BONDE AN, Martinussen T, Lee CJ, Lip GYH, et al
    Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation: An Instrumental Variable Analysis of a Nationwide Cohort.
    Circ Cardiovasc Qual Outcomes. 2020 Apr 14:CIRCOUTCOMES119006058.
    PubMed         Abstract available

  18. RESNIC FS, Majithia A, Dhruva SS, Ssemaganda H, et al
    Active Surveillance of the Implantable Cardioverter-Defibrillator Registry for Defibrillator Lead Failures.
    Circ Cardiovasc Qual Outcomes. 2020 Apr 14:CIRCOUTCOMES119006105.
    PubMed         Abstract available


  19. GRANGER CB, Mahaffey KW
    Preventing Atrial Fibrillation With Treatments for Diabetes Mellitus.
    Circulation. 2020;141:1235-1237.

    Clin Cardiol

  20. ZHANG H, Dong P, Yang X, Du L, et al
    Prognostic indicators of new onset atrial fibrillation in patients with acute coronary syndrome.
    Clin Cardiol. 2020 Apr 14. doi: 10.1002/clc.23363.
    PubMed         Abstract available

  21. STARREVELD R, Knops P, Ramos KS, Roos-Serote MC, et al
    Atrial fibrillation fingerprinting; spotting bio-electrical markers to early recognize atrial fibrillation by the use of a bottom-up approach (AFFIP): Rationale and design.
    Clin Cardiol. 2020 Apr 18. doi: 10.1002/clc.23370.
    PubMed         Abstract available

    Crit Care Med

  22. MORGAN RW, Reeder RW, Meert KL, Telford R, et al
    Survival and Hemodynamics During Pediatric Cardiopulmonary Resuscitation for Bradycardia and Poor Perfusion Versus Pulseless Cardiac Arrest.
    Crit Care Med. 2020 Apr 14. doi: 10.1097/CCM.0000000000004308.
    PubMed         Abstract available

    Eur Heart J

  23. MAURY P, Rollin A, Voglimacci-Stephanopoli Q, Delmas C, et al
    Termination of sustained ventricular fibrillation by catheter ablation.
    Eur Heart J. 2020 Apr 15. pii: 5820564. doi: 10.1093.

  24. SACHECK JM, Mozaffarian D
    Physical activity in patients with existing atrial fibrillation: time for exercise prescription?
    Eur Heart J. 2020;41:1476-1478.

  25. LINDE C
    Integrated care for atrial fibrillation: time for widespread use.
    Eur Heart J. 2020 Apr 13. pii: 5819644. doi: 10.1093.


  26. OTTO CM
    Heartbeat: smartwatch devices for detection of atrial fibrillation.
    Heart. 2020;106:627-628.

    Int J Cardiol

  27. CHEN L, Zinda A, Rossi N, Han XJ, et al
    A new risk model of assessing left atrial appendage thrombus in patients with atrial fibrillation - Using multiple clinical and transesophageal echocardiography parameters.
    Int J Cardiol. 2020 Apr 16. pii: S0167-5273(20)30157.
    PubMed         Abstract available

  28. CHEN Y, O'Mahony C
    The price and value of implantable cardioverter defibrillators in hypertrophic cardiomyopathy.
    Int J Cardiol. 2020 Apr 2. pii: S0167-5273(20)30939.

    J Cardiovasc Electrophysiol

  29. ANANNAB A, Gianni C, Della Rocca DG, Salwan AS, et al
    Catheter Ablation is Preferred over Surgery for Persistent Atrial Fibrillation.
    J Cardiovasc Electrophysiol. 2020 Apr 15. doi: 10.1111/jce.14497.
    PubMed         Abstract available

  30. CAY S, Ozeke O, Ozcan F, Topaloglu S, et al
    Impaired myocardial blood flow in atrial fibrillation.
    J Cardiovasc Electrophysiol. 2020 Apr 15. doi: 10.1111/jce.14494.

  31. PANTLIN PG, Bober RM, Bernard ML, Khatib S, et al
    In reply: Impaired myocardial blood flow in atrial fibrillation.
    J Cardiovasc Electrophysiol. 2020 Apr 15. doi: 10.1111/jce.14491.

    Approach to Recurrent Atrial Fibrillation with Isolated Pulmonary Veins.
    J Cardiovasc Electrophysiol. 2020 Apr 16. doi: 10.1111/jce.14503.
    PubMed         Abstract available

  33. TAMURA S, Nakajima T, Iizuka T, Hasegawa H, et al
    Unique Electrophysiological Properties of Fast-Slow Atrioventricular Nodal Reentrant Tachycardias Characterized by a Shortening of Retrograde Conduction Time via a Slow Pathway Manifested During Atrial Induction.
    J Cardiovasc Electrophysiol. 2020 Apr 16. doi: 10.1111/jce.14501.
    PubMed         Abstract available

    J Thromb Thrombolysis

  34. LIU W, Xiong N, Xie K, Wu B, et al
    A stricter control of low-density lipoprotein is necessary for thrombosis reduction in "lower thrombosis risk" patients with atrial fibrillation: a multicenter retrospective cohort study.
    J Thromb Thrombolysis. 2020 Apr 13. pii: 10.1007/s11239-020-02110.
    PubMed         Abstract available

    Pacing Clin Electrophysiol

  35. GIANCATERINO S, Nishimura M, Birgersdotter-Green U, Hoffmayer KS, et al
    Clinical factors associated with baseline history of atrial fibrillation and subsequent clinical outcomes following initial implantable cardioverter-defibrillator placement.
    Pacing Clin Electrophysiol. 2020 Apr 15. doi: 10.1111/pace.13919.
    PubMed         Abstract available

  36. LORING Z, Friedman DJ, Emerek K, Graff C, et al
    Lead one ratio in left bundle branch block predicts poor cardiac resynchronization therapy response.
    Pacing Clin Electrophysiol. 2020 Apr 14. doi: 10.1111/pace.13916.
    PubMed         Abstract available

    PLoS One

  37. SEMAKULA JR, Mouton JP, Jorgensen A, Hutchinson C, et al
    A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa.
    PLoS One. 2020;15:e0227458.
    PubMed         Abstract available

  38. KIM T, Kim KS, Suh GJ, Kwon WY, et al
    Duty cycle of 33% increases cardiac output during cardiopulmonary resuscitation.
    PLoS One. 2020;15:e0228111.
    PubMed         Abstract available


  39. MOHINDRA R, Lin S
    The drugs don't matter: Cardiovascular drugs have minimal effects on amplitude spectral area during ventricular fibrillation.
    Resuscitation. 2020 Apr 15. pii: S0300-9572(20)30146.

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.